| 價格 | 詢價 |
| 包裝 | 1removed |
| 最小起訂量 | 1removed |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-06-29 |
| 中文名稱:化合物 T14559 | 英文名稱:BI 224436 |
| CAS:1155419-89-8 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| 產(chǎn)品類別: 抑制劑 | |
| 貨號: T001|T14559 |
| 名稱 | BI 224436 |
| 描述 | BI 224436 is an inhibitor of HIV-1 noncatalytic site integrase. With EC50 values of less than 15 nM against different HIV-1 laboratory strains. |
| 體外活性 | BI 224436 has cellular cytotoxicity of more than 90 μM. BI 224436 has a low, 2.1-fold decrease in antiviral potency in the presence of 50% human serum. BI 224436 has drug-like in vitro absorption, distribution, metabolism, and excretion (ADME) properties, including Caco-2 cell permeability, solubility, and low cytochrome P450 inhibition[1]. BI 224436 retains full antiviral activity against recombinant viruses encoding INSTI resistance substitutions N155S, Q148H, and E92Q. BI 224436 displays an additive effect in combination with most approved antiretrovirals, including INSTIs. |
| 體內(nèi)活性 | BI 224436 exhibits excellent pharmacokinetic profiles in rat (clearance as a percentage of hepatic flow [CL], 0.7%; bioavailability [F], 54%), monkey (CL, 23%; F, 82%), and dog (CL, 8%; F, 81%)[1]. |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| 溶解度 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 2.5 mg/mL (5.65 mM), Sonication is recommended. DMSO : 50 mg/mL (112.99 mM), Sonication is recommended. |
| 關鍵字 | HIVProtease | HIV-1 | HIV Protease | BI-224436 | BI224436 | BI 224436 |
| 相關產(chǎn)品 | Valproic Acid | (-)-Epigallocatechin Gallate | Emtricitabine | Dextran sulfate sodium salt (MW 5000) | Lamivudine | 5-Fluorouracil | Decanedioic acid | Bromhexine hydrochloride | Chloroquine | Stavudine | Indole-2-carboxylic acid | Dimethyl fumarate |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 566.265100萬人民幣 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學,分子砌塊,生物技術服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
河北冀肽生物科技有限公司
|
2026-07-27 | ||
| 詢價 |
VIP1年
|
海南瀚海致遠生物科技有限公司
|
2026-06-10 | |
| 詢價 |
VIP8年
|
廣州市桐暉藥業(yè)有限公司
|
2026-06-02 | |
| 詢價 |
上海嘉定區(qū)澄瀏公路52號
|
2025-11-06 |